Toll-like receptors (TLRs) are sentinels of the host defense system, which recognize a large number of microbial pathogens. The host defense system may be inefficient or inflammatory diseases may develop if microbial recognition by TLRs and subsequent TLR-triggered cytokine production are deregulated. Activating transcription factor 4 (ATF4), a member of the ATF/CREB transcription factor family, is an important factor that participates in several pathophysiological processes. In this report, we found that ATF4 is also involved in the TLR-mediated innate immune response, which participates in TLR4 signal transduction and mediates the secretion of a variety of cytokines. We observed that ATF4 is activated and translocates to the nucleus following lipopolysaccharide (LPS) stimulation via the TLR4-MyD88-dependent pathway. Additionally, a cytokine array assay showed that some key inflammatory cytokines, such as IL-6, IL-8 and RANTES, are positively regulated by ATF4. We also demonstrate that c-Jun directly binds to ATF4, thereby promoting the secretion of inflammatory cytokines. Taken together, these results indicate that ATF4 acts as a positive regulator in TLR4-triggered cytokine production.
INTRODUCTION
The innate immune system plays a critical role in host defense against microbial pathogen invasion. Unlike the adaptive immune system, the innate immune system recognizes pathogens using receptors without rearrangement, such as Toll-like receptors (TLRs). TLRs are a type of pattern recognition receptor that recognizes molecular patterns that are broadly shared among microbial pathogens but distinguishable from host molecules and that are collectively referred to as pathogen-associated molecular patterns.
1 Upon pathogen-associated molecular pattern recognition, TLRs are activated and subsequently transduce signals from the cell membrane to the nucleus. Currently, two main branches of the TLR signal transduction pathway have been identified: the MyD88-dependent pathway and the TRIF-dependent pathway. 2, 3 Among the various TLR family members, TLR1, TLR2, TLR5, TLR6, TLR7, TLR8, TLR9, TLR10 and TLR11 activate the MyD88-dependent pathway, TLR3 provokes the TRIF-dependent pathway and TLR4 is capable of activating both the MyD88-and TRIF-dependent pathways. 4 The principal signaling pathways downstream of MyD88 are the TGF-beta-activated kinase (TAK)-nuclear factor (NF)-kB and TAK-mitogen-activated protein kinase (MAPK)-AP-1 pathways. 5 The activation of NF-kB and AP-1 promotes the secretion of multiple inflammatory factors. ATF4 , a member of the ATF/CREB transcription factor family, forms homodimers and heterodimers with other transcription factors, including some members of the AP-1 family. ATF4 plays an important role in many physical processes, such as the stress response, bone resorption, medullary hematopoiesis and lens formation. 6, 7 It remains unclear whether ATF4 participates in TLR signaling. Two observations suggesting that ATF4 participates in the TLR4 signaling pathway have been described. First, an ATF4 homologous molecule, ATF3, is an important negative regulator of the TLR4 signaling pathway.
Collection (ATCC No. CRL-11268). The 293T cells were cultured in DMEM medium supplemented with 10% fetal bovine serum, 2% L-glutamate, 1% non-essential amino acid and 1% sodium pyruvate. All cell lines were maintained at 37 uC in a 5% CO 2 incubator. The anti-TLR4-PE antibody (#12-9917-42) used for FACS analysis was obtained from eBioscience (San Diego, CA, USA). The Alexa Fluor 488-goat-anti-rabbit IgG (H1L) (#1008), Alexa Fluor 546-goat-antimouse IgG (H1L) (#11003), CD80-FITC (#8001) and CD86-PE (#8624) antibodies used for the FACS analysis were obtained from Invitrogen Life Technologies (Carlsbad, CA, USA). The ATF4 (#200), c-Jun (#44), phospho-c-Jun (#16312), AKT1/2/3 (#81434), phospho-AKT1/2/3 (#7985R), eIF2a (#133132), phospho-eIF2a (#101670), CHOP (#824), b-actin (#81178), CD44 (#53505), HRP-goat-antimouse (#2005) and HRP-goat-anti-rabbit (#sc-2004) antibodies used for western blot analysis were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The MyD88 (#3699) and TRIF (#4596) antibodies used for western blot analysis were purchased from Cell Signaling Technology (Beverly, MA, USA). The red anti-FLAG M2 affinity gel used for immunoprecipitation was purchased from Sigma-Aldrich (St Louis, MO, USA). LY294002, JNK inhibitors II 420119, PD98059 and SB202190 were purchased from Merck and Co (Darmstadt, Germany).
Plasmid construction
The lentivirus system containing three packaging vectors (pCMV-VSVG, pRRE and pRSV-REV) and the expression vectors (pLV-EF1a-IRES-bsd and pLV-H1-EF1a-puro) were obtained from Biosettia Company (San Diego, CA, USA). The ATF4, MyD88 and TRIF silence sites were screened on the Invitrogen web site using block-iT RNAi designer software. Short hairpin RNAs were obtained from Shenggong Company (Shanghai, China) and inserted into the pLv-EF1a-IRES-bsd plasmid. The target sequences of designed shRNAs are as follows: Leti-hATF4 ShRNA1: 59-GCC TAG GTC TCT TAG ATG A-39; Leti-hATF4 ShRNA2: 59-CAG ATT GGA TGT TGG AGA A-39; Leti-hMyD88 ShRNA1: 59-GCC TGT CTC TGT TCT TGA A-39; LetihMyD88 ShRNA4: 59-GCA AGG AAT GTG ACT TCC A-39; Leti-h-TRIF ShRNA2: 59-GCC AGG ACA AGC TCT TGT A-39; and the scramble control is: 59-GCT ACA CTA TCG AGC AAT T-39. Flagtagged full-length ATF4 was cloned into the pLv-EF1a-IRES-bsd vector via insertion of the PCR-amplified fragments using THP-1 cDNA and pCMV-TAG2b (Addgene).
RT-PCR and quantitative real-time PCR Total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) and reverse transcribed with PrimeScript RT reagent (TaKaRa, Shiga, Japan). The human genes were amplified using the following primers: hTLR1 (59-AGT TGT CAG CGA TGT TCG G-39/  59-GAT CAA GTA CCT TGA TCC TGG G-39); hTLR2 (59-GGC  TTC TCT GTC TTG TGA CC-39/59-GGG CTT GAA CCA GGA  AGACG-39); hTLR3 (59-AGC CAC CTG AAG TTG ACT CAG G-39/59 CAG TCA AAT TCG TGC AGA AGG C-39); hTLR4 (59-GCA  ACA CCT TCA GAT AAG CAG-39/59-AAG ATG ATT ACC AGC  ACG ACG ACT G-39); hTLR5 (59-TTC TGG AAA TGG CTG GAC  AG-39/59-TCG GAG ATC CAA GGT CTG TAA T-39); hTLR6 (59-CCT GGG AGG TAA ACA TCT GA-39/59-CCC TCA ACC ACA TAG  AAA CGA-39); hTLR7 (59-GAT AAC AAT GTC ACA GCC GTC C-39/  59-GTT CCT GGA GTT TGT TGA TGT TC-39); hTLR8 (59-CAG  GGA CTT GCT TTC CAG GT-39/59-ACA CGG AAA CCC CTT  TGA ATG-39); hTLR9 (59-CGC CAA CGC CCT CAA GA-39/59-GCA TCC TCA TCT CGC CCA CT-39); hTLR10 (59-AAG CCC  ACA TTT ACG CCT ATC-39/59-CCG CGC TGG CGG AGG AGA   TGG AC-39); hMyD88 (59-CTC CTC CAC ATC CTC CCT T-39/59-CAG TGG GGT CCG CTT GT-39); hTRIF (59-GGT ATC AAA CCC  GGA ATA ATC-39/59-GTT GTG TCT TAT ACA CAG ACT CCT G-39); and hGAPDH (59-CTG ATG CCC CCA TGT TCG TC-39/59-CAC  CCT GTT GCT GTA GCC AAA TTC-39) . SYBR Premix Ex Taq (TaKaRa) was used to amplify cDNA for real-time PCR. The primers used for real-time PCR are as follows: hATF4 (59-GTC AGT CCC TCC AAC AAC A-39/59-GGT GTC TTC CTC CTT TAT GC-39) and hbactin (59-GGC ATC CAC GAA ACT ACC TT-39/59-CTC GTC ATA CTC CTG CTT GC-39). Data analysis was performed using GelDoc XR (BioRad, Berkeley, CA, USA).
Lentiviral transduction and virus infection
The 293T cell line was transfected using the lentivirus system with Lipofectamine-2000 (Invitrogen) according to the manufacturer's instructions. Forty hours after the transfection, the supernatant was collected and centrifuged to harvest the lentivirus. The virus titers were measured, and the THP-1 cells were incubated with lentivirus (virus titer510 7 /ml; MOI520) in a centrifuge at 1000g for 1 h at 37 uC. Then, complete medium was added to the THP-1 cells, which were incubated for an additional 36 h to allow for the expression of the target genes.
Flow cytometry
The cells were fixed with 4% fixation/penetration buffer (BD Bioscience, Franklin Lakes, NJ, USA) for 15 min at 25 uC and blocked with blocking buffer (phosphate-buffered saline with 1% bovine serum albumin) for 30 min on ice. The cells were incubated with either anti-ATF4 antibody or anti-TLR4-PE antibody for 30 min on ice, washed three times with permeabilization buffer (BD Bioscience) and then incubated with Alexa Fluor 488 goat anti-rabbit IgG (H1L) antibody for 30 min. Next, the cells were washed again and resuspended in 500 ml of phosphate-buffered saline, and the BD FACSCalibur and software CellQuest Pro were used to perform the FACS analysis.
Western blot and immunoprecipitation
Total cell protein was prepared by lysing the cells with radioimmunoprecipitation assay (RIPA) buffer (20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM b-glycerophosphate, 1 mM Na 3 VO 4 , 1 mg/ml leupeptin and 1 mM PMSF), and the protein concentration was determined using the bicinchoninic acid (BCA) protein assay reagent (Pierce, Rockford, IL, USA). Cytoplasmic protein and nucleoprotein were obtained using a Nuclear Cytosol Extraction Kit (KeyGEN BioTECH, Nanjing, China). For western blot analysis, 30 mg of each sample was fractionated via 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis and then transferred to a nitrocellulose membrane. The membrane was visualized using ECL solution (Millipore, Billerica, MA, USA) after blocked with 5% bovine serum albumin and probed with primary and secondary antibodies.
Immunoprecipitation was performed as described in the red anti-FLAG affinity gel technical bulletin (#F2426; Sigma-Aldrich, Steinheim, Germany) with slight modifications. Briefly, THP-1 cells plated in 75-mm 2 flasks were transfected with either the FLAG-ATF4 or control vectors. Forty-eight hours later, the cells were starved overnight, stimulated with 100 ng/ml lipopolysaccharide (LPS) for 30 min and lysed in 800 ml of cell lysis buffer (50 mM Tris HCl (pH 7.4), 150 mM NaCl, 1% EDTA, 1% NP-40, 100 mM NaF and 100 mM Na 3 VO 4 ). After centrifugation at 13 800g for 15 min at 4 uC and quantification with a BCA protein assay kit (Thermo, Rockford, IL, USA), 500 mg of whole cell lysate was incubated with 30 ml of anti-FLAG M2 affinity gel at 4 uC overnight with gentle rotation. The beads were washed four times with cell lysis buffer, and the precipitates were eluted with 23 sodium dodecyl sulfate polyacrylamide gel electrophoresis sample buffer and analyzed via western blot using the anti-ATF4 and anti-p-c-Jun antibodies as described above. To monitor the protein expression levels, 30 mg of total cell lysate was loaded as a positive control.
Immunofluorescence THP-1 cells were treated with 100 ng/ml LPS for 5, 15, 30 and 60 min and immediately centrifuged in 24-well plates, which had a coverslip in each well. The cells were fixed with 4% paraformaldehyde for 15 min at 25 uC and penetrated with 0.5% Triton X-100 for 15 min at 25 uC. Next, the cells were stained with fluorochrome-labeled antibodies and DAPI (Sigma-Aldrich, Steinheim, Germany). Images were acquired using a laser scanning confocal microscope (#TCS SP5; Leica, Heidelberg, Germany).
ELISA and human cytokine array
After treatment of the THP-1 cells with LPS (100 ng/ml) for 16 h, the supernatant was harvested. The concentration of IL-6, IL-8 and tumor-necrosis factor-a (TNF-a) in the cell supernatant was assessed on ELISA plates (#D8000C, #D6050 and #DTA00C, respectively; R&D Systems, Minneapolis, MN, USA) according to the manufacturer's instructions. A human cytokine array was performed using the Human Cytokine Array Panel A (#ARY005; R&D Systems). For this experiment, the cell density was 1310 6 cells/ml. ATF4 knockdown cells and normal cells were treated for 16 h with 100 ng/ml LPS (SigmaAldrich, Steinheim, Germany). The supernatant derived from the cell culture was collected, and 500 ml of medium was used for each array.
Statistical analysis
The values are expressed as the mean6s.d. Statistical analysis was performed using the Student's t-test to compare the data for the experimental and control or vehicle-treated groups. The differences were considered significant at P,0.05.
RESULTS

ATF4 is activated via the TLR4 signaling pathway
Previous work has demonstrated that THP-1, a human acute monocytic leukemia cell line, is sensitive to microbial recognition and secretes a mass of cytokines following activation. 11 We found that TLR1-10, MyD88 and TRIF are transcriptionally expressed in THP-1 cells (Figure 1a ), and we discovered via FACS analysis that almost all the cells simultaneously express ATF4 and TLR4 ( Figure 1b ). As shown in Figure 1c , TLR4 is localized to the plasma membrane, while ATF4 is uniformly distributed throughout the entire cell.
To further investigate whether the TLR signaling pathway activates ATF4, we treated THP-1 cells with a low-dose series of LPS, the specific ligand of TLR4. The results of the western blot analysis indicated that ATF4 levels increased at the translational level after stimulation, especially at 100 ng/ml LPS (Figure 2a ), which is consistent with the observed pathophysiological stimulation in chronic inflammatory diseases and has been adopted as a surrogate stimulator in these conditions by many studies. 12, 13 Activated ATF4 forms homogenic and heterogenic dimers and translocates into the cell nucleus for further regulation. 6, 7 To investigate the dynamics of LPS-induced ATF4 translocation, the expression levels of ATF4 in the cytoplasm and nucleus were assessed via western blot and compared with the total protein levels. The results displayed in Figure 2c -e show that both total ATF4 and nuclear ATF4 levels increased at 1 h after LPS stimulation. Quantitative real-time PCR analysis showed that there was no significant alteration in mRNA levels ( Figure 2b ). These findings suggest that both LPS induces ATF4 translational activity and ATF4 is involved in the TLR signaling pathway.
To further assess the translocation activity of ATF4, we imaged the translocation of ATF4 upon LPS stimulation at 5, 15, 30 and 60 min via confocal microscopy. ATF4 fluorescence had a diffused cellular distribution in both the cytoplasm and nucleus before stimulation (Figure 3a and k) . However, as shown in Figure 3b and i, ATF4 translocated to the cytomembrane and formed a crescent-like structure at 5 min. At 15 min, ATF4 protein gradually moved into the cell nucleus. At the 60-min time point, ATF4 was completely localized at the nucleus. These experiments were repeated using the U937 cell line, a human leukemic monocyte lymphoma cell line, which yielded the same results (Supplementary Figure 1a-c) . CD44 antigen, a cellsurface glycoprotein expressed in both THP-1 and U937 cells, was used to label the cellular membrane. These data strongly demonstrate that ATF4 is directly activated by TLR signaling, which functions not Figure 2b) . After the virus-infected cells were treated with 100 ng/ml LPS for 16 h, 
we compared the variations in cytokine secretion in the cell culture supernatants between the ATF4-deficient and wild-type cells using a human cytokine array assay. As shown in Figure 4b , the round spots represent different cytokines, which are thinner in the ATF4 knockdown group compared with the wild-type control. Based on the statistical analysis (Figure 4c) Figure 3) , respectively, and the results were consistent with the above findings (Figure 4d and Supplementary Figure 4) . Taken together, these results indicate that ATF4 positively regulates TLR4-trigged cytokine production.
TLR4 activates ATF4 via the MyD88-dependent pathway Two main downstream branches of TLR signaling have been described, and TLR4 is the only receptor known to activate both the MyD88-dependent and the TRIF-dependent pathways, which mediate the production of proinflammatory cytokines and type 1 IFN, respectively. 15, 16 Currently, two reports have described the pathway regulation of ATF4 activation, although there is no consensus between them. Woo et al. 17 found that the expression of CHOP and its activator, ATF4, which are induced by ER stress, was suppressed via prior engagement with TLR3 or TLR4 via a TRIF-dependent pathway. Bandow et al. 18 reported that during osteoblast differentiation, LPS decreased the mRNA expression levels of ATF4 in wild-type cells but not in MyD88
osteoblasts. However, the cytokine array results suggest that ATF4 knockdown primarily interferes with the secretion of cytokines regulated by the MyD88-dependent pathway. Therefore, we designed and constructed four shRNAs targeting MyD88 and TRIF. After MyD88 or TRIF expression was silenced in THP-1 cells with the most effective shRNAs (MyD88 ShRNA4-1 and TRIF ShRNA2-3, as shown in the Supplementary Figure 5a and b), the activation of ATF4 was assessed after LPS stimulation. Figure 5a -d shows in MyD88 knockdown cells but not in TRIF knockdown cells, that the levels of ATF4 increased in the cytoplasm after LPS stimulation, while ATF4 was restrained to the cytoplasm and unable to translocate to the cell nucleus, which demonstrates that MyD88 plays an important role in the translocation of ATF4.
To further confirm the above results, we imaged the translocation of ATF4 in the two knockdown groups and the scramble group using a confocal microscope. As shown in Figure 5e , during the first 5 min, ATF4 was recruited to the cytoplasm in both the MyD88-deficient and ATF4 positively regulates TLR4-triggered cytokine production CY Zhang et al 88 TRIF-deficient cells. However, the status then changed in the TRIF knockdown cells; ATF4 began to transfer to the cell nucleus at 15 min, which is consistent with the scramble control (data not shown), while in the MyD88 knockdown cells, ATF4 translocation to cell nucleus was hampered. Taken together, these results strongly suggest that both TLR4 induces ATF4 activation via the MyD88-dependent pathway and MyD88 is required for ATF4 to translocate to the cell nucleus where ATF4 further regulates the secretion of cytokines (Supplementary Figure 6a and b) .
JNK is involved in the activation of ATF4 via TLR4 signaling
In the MyD88-dependent signaling pathway, MyD88 binds to TLRs via Toll/IL-1 receptor (TIR) domains. Upon stimulation, IRAK-4, IRAK-1 and TRAF6 are recruited to MyD88 and then activate the TAK1/TAB1/2 complex. 19 Activated TAK1 phosphorylates the IKK complex (IKKa, IKKb, IKKc and NIK-IKKa) and then induces the activation of NF-kB. 20 Activated TAK1 also phosphorylates MAPKs, including p38, ERK1/2 and JNK, to induce the activation of AP-1. 21, 22 ERK1/2 primarily regulates cell differentiation and proliferation, while p38 and JNK play an important role in inflammation, the stress response and cell survival/apoptosis. To determine whether MAPKs have an effect on the activation of ATF4 upon LPS stimulation, we performed experiments using four kinase inhibitors. THP-1 cells were pretreated with 40 nM JNK inhibitor II (JNK 420119), 10 mM PI3K inhibitor (LY294002), 20 mM MEK/MAPKK inhibitor (PD98059), 10 mM p38 MAP kinase inhibitor (SB203580) and dimethyl sulfoxide (DMSO) (as a negative control) for 30 min and subsequently treated with LPS for 60 min. The ATF4 protein levels were assessed via western (Figure 6a ) and the nucleoprotein (Figure 6c ) but had no effect on cytoplasmic protein (Figure 6b ). To ascertain whether toxicity caused by the drugs influenced the results, the WST-1 assay was used to test cell viability. The result revealed that DMSO and the inhibitors had, on average, little or no effect on the cells within 2 h (Supplementary Figure 7a) .
We also imaged the translocation of ATF4 in the cells and obtained the same results. As shown in Figure 6d , upon pre-treatment with JNK 420119 and LY294002, ATF4 was blocked in the cytoplasm and was unable to transfer to the cell nucleus, in contrast to the results observed for the DMSO control. However, the effect on ATF4 in response to PD98059 and SB203580 was similar to that of the DMSO control group. Therefore, in the TLR4-triggered MyD88-dependent pathway, JNK facilitates ATF4 activation by inducing its translocation into the cell nucleus. Therefore, JNK may be the key mediator in the interaction between TLR4 and ATF4.
ATF4 interacts with c-Jun and promotes gene transcription MAPK activity induces the activation of AP-1, which is a family of transcription factors (c-Jun and c-Fos) containing a leucine zipper domain.
23 ATF4 forms heterodimers with c-Jun and c-Fos via its leucine zipper domain. 24 Currently, JNK is the only kinase known to phosphorylate and activate c-Jun (Figure 7a) . 25, 26 Therefore, we hypothesized that upon LPS stimulation in our experimental model, phosphorylated c-Jun forms a dimer with activated ATF4 and then translocates into the cell nucleus to bind to the target genes and regulate their transcription. Therefore, we examined p-c-Jun and p-AKT at 0, 5, 15, 30, 60 and 120 min after LPS stimulation and found that p-cJun levels but not p-AKT levels were increased at 120 min (Figure 7b and Supplementary Figure 8a and b) , similar to the increase in ATF4 in the cell nucleus (Figure 2c) . Furthermore, the expression of c-Jun in the nucleus decreased following ATF4 knockdown (Figure 7c ). To further investigate the mechanism underlying the interaction between ATF4 and c-Jun, we performed an immunoprecipitation assay. A Flag tag was linked to ATF4, and the fusion protein was precipitated using a Flag antibody. Figure 7d shows that c-Jun binds to ATF4 and may then promote the gene transcription activity of ATF4 via this interaction.
Consequently, these data prompted us to propose the following molecular mechanism (Figure 8 ). In the TLR4 signaling pathway, upon LPS stimulation, MyD88 is recruited to TLR4 via its TIR domain, and then MyD88 recruits IRAK and TRAF6, which activate the TAK1 and TAB1/2/3 complex. The activated complex phosphorylates JNK and then phosphorylates c-Jun, which forms heterodimers with ATF4 via the leucine zipper. This dimer binds to DNA and promotes the transcription of certain genes, thereby resulting in the secretion of relevant inflammatory cytokines.
DISCUSSION
The innate immune response is the first defense system of the immune system following activation by microbial pathogens. The types of secreted cytokines and activated innate immune cells determine the type and strength of the adaptive immunity response. 27 TLR signaling represents one of the key mechanisms involved in these processes. 28 Although ATF3, an ATF4 homologue, has been reported to participate in the TLR4 signaling pathway 8, 29 and recent reports have indicated that ATF4 is capable of regulating cytokine secretion, 9 it remains unclear whether ATF4 plays a role in TLR signaling. In this study, we defined a novel mechanism in which ATF4 is recruited by TLR4 signaling via the MyD88-dependent pathway, translocates to the nucleus and stimulates TLR-triggered cytokine production to further promote an inflammatory reaction. It has been established that ATF4 is primarily induced via metabolic stress (such as glucose and amino acid deprivation), oxidative stress and ER stress. A growing body of evidence has suggested that ATF4 may also interact with the TLR signaling pathway. Shimasaki et al. 30 have shown that ER stress increases TLR2 expression levels in human epithelial cells and ER stress enhances TLR2-dependent proinflammatory cytokine production. Woo et al. 17 have demonstrated that TLR signaling is a negative regulator of the ATF4-CHOP pathway. In this study, we provided evidence that ATF4 is directly induced by TLR4 signaling instead of via ER stress ( Supplementary Figure 9c and 10 34 have also been shown to stimulate ATF4 production via the ER stress response. The lentivirus infection system that we used in the experiment is only sustained for 1 h, and a scramble control was included, which have been used in many other studies. 35, 36 ATF4 acts as a transcription activator and inhibitor. 35, [37] [38] [39] [40] The results of our cytokine array assay revealed that ATF4 positively regulated the secretion of RANTES, sICAM-1, IL-6, IL-8 and IFN-c, all of which are proinflammatory cytokines. RANTES, a representative chemotactic factor, mediates T cell differentiation and cytokine release, and it is also a chemoattractant for blood monocytes, memory Thelper cells, mast leukocyte and eosinophils. 41 sICAM-1 mediates adhesion between leukocytes and endotheliocytes and participates in inflammation and immunity processes. 42 IL-8, IL-6, IFN-c and TNF-a are critical cytokines that have been implicated in a variety of inflammatory conditions. 43, 44 In the present study, we used THP-1 cells, a human monocyte-macrophage cell line, as monocytes and macrophages have been shown to be critically involved in the pathogenesis of inflammatory diseases. Monocytes migrate from the bloodstream to inflamed tissues, including the joint and bowel, and differentiate into macrophages, thereby developing into the primary source of proinflammatory cytokines. 43, 45 Our data demonstrate that ATF4 may promote inflammation by upregulating these pro-inflammatory cytokines and chemokines after activation.
According to current studies, ATF4 activity is primarily regulated at the post-transcriptionally level, especially the translation of ATF4 mRNA.
46,47 ATF4 protein degrades quickly, and its half-life is only 30-60 min. 48, 49 The confocal microscopy images showed that as early as 5 min after LPS stimulation, ATF4 translocated to the cytoplasmic membrane, and 15 min after stimulation, we observed the nuclear translocation of ATF4. Moreover, we treated the cells with 1 mg/ml tunicamycin and 100 ng/ml LPS for 12 h and detected the expression of phosphorylated eIF2a and CHOP. Supplementary Figure 9c shows that treatment with 100 ng/ml LPS fails to induce ER stress and significant phosphorylation of eIF2a. Thus, the increase in ATF4 levels after LPS stimulation may partly be due to the enhanced ATF4 stability.
The TLR signaling pathway consists of the MyD88-dependent pathway, which is common to most TLRs, and the TRIF-dependent pathway that distinctly involves the TLR3 and TLR4 signaling pathways. 2 Studies regarding the ATF4 subpathway are very limited, and the opinions are contradictory. Woo et al. 17 have found that the expression of Figure 8 The summary of the molecular mechanism of ATF4 involvement in TLR4-triggered cytokine production as described in the text. ATF4, activating transcription factor 4; TLR, Toll-like receptor.
ATF4 positively regulates TLR4-triggered cytokine production CY Zhang et al 92 ER stress-induced CHOP and ATF4 was suppressed by prior engagement with TLR3 or TLR4 via the TRIF-dependent pathway. Nonetheless, he also claimed that low-dose LPS (1-100 ng/ml) treatment prevents cellular ER stress. 17 Endo et al. 50 have used LPS (160 mg/kg of body weight) in a mouse model, and Gotoh et al. 51 have used LPS (150 mg/ml) plus IFN-c (100 units/ml) to induce ER stress. In our study, we found that low-dose LPS treatment activated ATF4. Our results reveal that ATF4 positively regulates TLR-triggered cytokine production via the MyD88-dependent subpathway. In MyD88 knockdown cells, ATF4 was blocked in the cytoplasm following LPS stimulation and failed to translocate to the cell nucleus to exert the transcription-promoting function, while TRIF knockdown had minor suppressive effects on ATF4 function.
ATF4 is thought to form heterodimers with the C/EBPs and AP-1 transcription factors. 52, 53 In the present study, we investigated c-Jun as the possible downstream mediator of ATF4 in the TLR4-trigged signaling pathway, which was prompted by previous reports showing that heterodimerization of ATF4 and c-Jun might occur. 36, 54 The study by An et al. 26 has indicated that there is an AP-1 response element within the IL-6 promoter. The RANTES/CCL5 promoter displays binding activity with AP-1, C/EBP and NF-kB, 55 while the IL-8 promoter contains NF-kB, AP-1, OCT-1 and C/EBP-binding sites. [56] [57] [58] The studies by Hadad et al. 59 and Clarke et al. 60 have revealed that there is a CREB-binding site within the sICAM-1 and IFN-c promoter. Promoter analysis by Yeligar et al. 61 has revealed that c-Jun, c-Jun/c-Fos and JunD, but not JunB, bind to the AP-1 site of the promoters. The results of our IP experiment indicated that upon LPS stimulation, ATF4 forms dimers with c-Jun via the AP-1 and CREB binding sites, which may promote the secretion of various proinflammatory cytokines.
Taken together, the data reveal a novel mechanism in which ATF4 is both involved in an inflammatory reaction trigged by the TLR4 signaling pathway and positively regulates the production of some cytokines via interaction with c-Jun. Whether ATF4 represents a target for the regulation of cytokine secretion to further control inflammatory diseases will be addressed in future studies.
